Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0050863,GO:0050863,regulation of T cell activation,32/105,342/18800,1.3428527246479298e-30,3.94664415774026e-27,2.11888024657605e-27,ADAM8/B2M/CCL21/CD27/CD274/CD28/CD5/CD70/CD74/CD80/CD83/CD86/CRTAM/HLA-E/IL10/IL12B/IL12RB1/IL18/IL2RA/IL4R/IL6/KLRK1/LAG3/LGALS9/LILRB1/LILRB4/PTPRC/TIGIT/TNFRSF13C/TNFRSF1B/TNFSF8/VCAM1,32
GO:0022409,GO:0022409,positive regulation of cell-cell adhesion,30/105,291/18800,6.362103074058309e-30,8.09568791280107e-27,4.34642509313544e-27,ADAM8/B2M/CCL21/CD27/CD274/CD28/CD5/CD70/CD74/CD80/CD83/CD86/CXCL13/HLA-E/IL10/IL12B/IL12RB1/IL18/IL2RA/IL4R/IL6/KLRK1/LGALS9/LILRB1/LILRB4/PLAUR/PTPRC/TNF/TNFRSF13C/VCAM1,30
GO:0032944,GO:0032944,regulation of mononuclear cell proliferation,28/105,233/18800,8.263716821505009e-30,8.09568791280107e-27,4.34642509313544e-27,BCL2/CD22/CD274/CD28/CD70/CD74/CD80/CD86/CRTAM/CSF1/FCRL3/HLA-E/IL10/IL12B/IL12RB1/IL18/IL2RA/IL6/LGALS9/LILRB1/LILRB4/PTPRC/TNFRSF13B/TNFRSF13C/TNFRSF1B/TNFRSF4/TNFSF8/VCAM1,28
GO:0007159,GO:0007159,leukocyte cell-cell adhesion,32/105,381/18800,4.28797613736119e-29,2.10039364461742e-26,1.12766249647446e-26,ADAM8/B2M/CCL21/CD27/CD274/CD28/CD5/CD70/CD74/CD80/CD83/CD86/CRTAM/GCNT1/HLA-E/IL10/IL12B/IL12RB1/IL18/IL2RA/IL4R/IL6/KLRK1/LAG3/LGALS9/LILRB1/LILRB4/PTPRC/TIGIT/TNF/TNFRSF13C/VCAM1,32
GO:1903131,GO:1903131,mononuclear cell differentiation,33/105,433/18800,1.20122288706671e-28,4.4129925813613096e-26,2.36925408909604e-26,ADAM8/B2M/BCL2/BLNK/CD27/CD28/CD74/CD79B/CD80/CD83/CD86/CR2/CRTAM/CSF1/DLL1/FCRL3/IL10/IL12B/IL12RB1/IL18/IL2RA/IL4R/IL6/LAG3/LGALS9/LILRB1/LILRB4/LY9/PTPRC/SLAMF6/SLAMF8/TNFSF8/VCAM1,33
GO:0050670,GO:0050670,regulation of lymphocyte proliferation,27/105,230/18800,1.86250643968073e-28,6.08211825135741e-26,3.2653767872297296e-26,BCL2/CD22/CD274/CD28/CD70/CD74/CD80/CD86/CRTAM/FCRL3/HLA-E/IL10/IL12B/IL12RB1/IL18/IL2RA/IL6/LGALS9/LILRB1/LILRB4/PTPRC/TNFRSF13B/TNFRSF13C/TNFRSF1B/TNFRSF4/TNFSF8/VCAM1,27
GO:0032943,GO:0032943,mononuclear cell proliferation,29/105,300/18800,4.32064267914001e-28,1.26983688339925e-25,6.817519343190389e-26,BCL2/CD22/CD274/CD28/CD70/CD74/CD80/CD86/CR2/CRTAM/CSF1/FCRL3/HLA-E/IL10/IL12B/IL12RB1/IL18/IL2RA/IL6/LGALS9/LILRB1/LILRB4/PTPRC/TNFRSF13B/TNFRSF13C/TNFRSF1B/TNFRSF4/TNFSF8/VCAM1,29
GO:0002696,GO:0002696,positive regulation of leukocyte activation,32/105,421/18800,1.02227036086267e-27,2.41354497776177e-25,1.29578765482885e-25,ADAM8/B2M/BCL2/CCL21/CCL3/CD27/CD274/CD28/CD5/CD70/CD74/CD80/CD83/CD86/FCRL3/HLA-E/IL10/IL12B/IL12RB1/IL18/IL2RA/IL4R/IL6/KLRK1/LGALS9/LILRB1/LILRB4/PTPRC/TNF/TNFRSF13C/TNFRSF4/VCAM1,32
GO:0002697,GO:0002697,regulation of immune effector process,30/105,353/18800,2.16695316500096e-27,4.549053822812741e-25,2.44230285288454e-25,B2M/CD22/CD28/CD74/CD80/CD86/CR2/CRTAM/FCER2/FCRL3/HLA-E/IL10/IL12B/IL12RB1/IL18/IL4R/IL6/KLRK1/LAG3/LGALS9/LILRB1/LILRB4/LTA/PTPRC/SEMA7A/SLAMF6/SLAMF8/TNF/TNFRSF1B/TNFRSF4,30
GO:0050870,GO:0050870,positive regulation of T cell activation,26/105,223/18800,2.53841826821296e-27,4.973607526851921e-25,2.6702378835447204e-25,ADAM8/B2M/CCL21/CD27/CD274/CD28/CD5/CD70/CD74/CD80/CD83/CD86/HLA-E/IL12B/IL12RB1/IL18/IL2RA/IL4R/IL6/KLRK1/LGALS9/LILRB1/LILRB4/PTPRC/TNFRSF13C/VCAM1,26
GO:0046651,GO:0046651,lymphocyte proliferation,28/105,296/18800,7.56854098199768e-27,1.23577455256062e-24,6.6346449894821805e-25,BCL2/CD22/CD274/CD28/CD70/CD74/CD80/CD86/CR2/CRTAM/FCRL3/HLA-E/IL10/IL12B/IL12RB1/IL18/IL2RA/IL6/LGALS9/LILRB1/LILRB4/PTPRC/TNFRSF13B/TNFRSF13C/TNFRSF1B/TNFRSF4/TNFSF8/VCAM1,28
GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,30/105,370/18800,8.82297664993009e-27,1.36477517758655e-24,7.32722548379236e-25,B2M/BTN3A2/C1QA/CD27/CD274/CD28/CD70/CD74/CD80/CLEC6A/CR2/CXCL13/FCER2/HLA-E/IL10/IL12B/IL12RB1/IL18/IL18BP/IL4R/IL6/LILRB1/LILRB4/LTA/LY9/PTPRC/SLAMF6/SWAP70/TNF/TNFRSF1B,30
GO:0002449,GO:0002449,lymphocyte mediated immunity,28/105,365/18800,2.61550481704421e-24,3.4940766624058797e-22,1.8759051295451099e-22,B2M/BTN3A2/C1QA/CD27/CD28/CD70/CD74/CR2/CRTAM/FCER2/HLA-E/IL10/IL12B/IL12RB1/IL18/IL4R/IL6/KLRK1/LAG3/LGALS9/LILRB1/LILRB4/LTA/PTPRC/SLAMF6/SWAP70/TNF/TNFRSF1B,28
GO:0001819,GO:0001819,positive regulation of cytokine production,30/105,475/18800,1.37676798115174e-23,1.75927004200216e-21,9.44519544048721e-22,ADAM8/B2M/BTN3A2/CCL3/CD274/CD28/CD74/CD80/CD83/CD86/CLEC6A/CRTAM/HLA-E/IL10/IL12B/IL12RB1/IL18/IL4R/IL6/KLRK1/LGALS9/LILRB1/LTA/LY9/PTPRC/SEMA7A/SLAMF6/TIGIT/TNF/TNFRSF8,30
GO:1902105,GO:1902105,regulation of leukocyte differentiation,24/105,283/18800,6.95410575911723e-22,6.81270560868184e-20,3.65761562558482e-20,ADAM8/CCL3/CD27/CD28/CD74/CD80/CD83/CD86/CRTAM/CSF1/FCRL3/IL10/IL12B/IL12RB1/IL18/IL2RA/IL4R/LAG3/LGALS9/LILRB1/LILRB4/PTPRC/SLAMF8/TNF,24
GO:0046631,GO:0046631,alpha-beta T cell activation,20/105,158/18800,7.720298543599659e-22,7.09061169363731e-20,3.80681826212365e-20,BCL2/CD274/CD28/CD80/CD83/CD86/CRTAM/HLA-E/IL12B/IL12RB1/IL18/IL4R/IL6/LGALS9/LILRB1/LILRB4/LY9/PTPRC/SLAMF6/TNFSF8,20
GO:0002819,GO:0002819,regulation of adaptive immune response,21/105,188/18800,9.88351272769417e-22,8.802316335361571e-20,4.7258008225880605e-20,B2M/CD274/CD28/CD48/CD80/CLEC6A/CR2/FCER2/HLA-E/IL10/IL12B/IL12RB1/IL18/IL4R/IL6/LILRB1/LILRB4/LTA/PTPRC/TNF/TNFRSF1B,21
GO:0002700,GO:0002700,regulation of production of molecular mediator of immune response,18/105,167/18800,1.92068437127618e-18,1.37680277248309e-16,7.39179941602821e-17,B2M/CD22/CD28/CD74/CD86/FCRL3/HLA-E/IL10/IL18/IL4R/IL6/LILRB1/LILRB4/PTPRC/SEMA7A/TNF/TNFRSF1B/TNFRSF4,18
GO:0042113,GO:0042113,B cell activation,22/105,336/18800,1.13140286337308e-17,7.73300701268249e-16,4.15170842642899e-16,BCL2/BLNK/CD22/CD27/CD28/CD70/CD74/CD79B/CD86/CR2/DLL1/FCRL1/FCRL3/IL10/IL6/PTPRC/SLAMF8/SWAP70/TNFRSF13B/TNFRSF13C/TNFRSF4/VCAM1,22
GO:0002285,GO:0002285,lymphocyte activation involved in immune response,17/105,201/18800,1.13139287559953e-15,6.5199287478177e-14,3.50042914452776e-14,CD28/CD74/CD80/CD86/DLL1/IL10/IL12B/IL12RB1/IL18/IL4R/IL6/LGALS9/LILRB1/LY9/PTPRC/SLAMF6/SWAP70,17
GO:0019221,GO:0019221,cytokine-mediated signaling pathway,23/105,486/18800,2.2687904898044803e-15,1.23481023139544e-13,6.62946772751835e-14,CCL21/CCL3/CD70/CD74/CSF1/CXCL13/CXCL9/EDA2R/IFNLR1/IL12B/IL12RB1/IL18/IL2RA/IL4R/IL6/LILRB1/LILRB4/PTPRC/TNF/TNFRSF13C/TNFRSF17/TNFRSF1B/TNFRSF4,23
GO:0032609,GO:0032609,interferon-gamma production,14/105,117/18800,3.3613425328860203e-15,1.73315538669333e-13,9.30499068660413e-14,BTN3A2/CD274/CRTAM/IL10/IL12B/IL12RB1/IL18/KLRK1/LGALS9/LILRB1/LILRB4/LTA/SLAMF6/TNF,14
GO:0002237,GO:0002237,response to molecule of bacterial origin,20/105,354/18800,6.7760131788485104e-15,3.43356943666134e-13,1.84341991925479e-13,B2M/CCL3/CD274/CD80/CD86/CXCL13/CXCL9/IL10/IL12B/IL18/IL18BP/IL6/KLRK1/LGALS9/LILRB1/LTA/NOS3/TNF/TNFRSF1B/VCAM1,20
GO:0002440,GO:0002440,production of molecular mediator of immune response,19/105,312/18800,8.86421794543272e-15,4.4155824646825e-13,2.3706445495457e-13,B2M/CD22/CD28/CD74/CD86/FCRL3/HLA-E/IL10/IL18/IL4R/IL6/LILRB1/LILRB4/PTPRC/SEMA7A/SWAP70/TNF/TNFRSF1B/TNFRSF4,19
GO:0032103,GO:0032103,positive regulation of response to external stimulus,21/105,442/18800,4.0532806117698904e-14,1.8631643016673097e-12,1.00029845031403e-12,ADAM8/CCL21/CCL3/CD28/CD74/CLEC6A/CRTAM/CSF1/CXCL13/HLA-E/IL12B/IL18/IL6/KLRK1/LAG3/LGALS9/LTA/PGF/SLAMF6/SWAP70/TNF,21
GO:0050866,GO:0050866,negative regulation of cell activation,16/105,216/18800,6.70484603958332e-14,2.98568825914172e-12,1.60296079957502e-12,CD274/CD74/CD80/CD86/CRTAM/IL10/IL2RA/IL4R/LAG3/LGALS9/LILRB1/LILRB4/NOS3/PTPRC/TIGIT/TNFRSF13B,16
GO:0050868,GO:0050868,negative regulation of T cell activation,13/105,125/18800,2.18778468746492e-13,9.185570280656299e-12,4.93156277670665e-12,CD274/CD74/CD80/CD86/CRTAM/IL10/IL2RA/IL4R/LAG3/LGALS9/LILRB1/LILRB4/TIGIT,13
GO:0031341,GO:0031341,regulation of cell killing,12/105,100/18800,3.3770794723359997e-13,1.3412481850264199e-11,7.2009134125628296e-12,B2M/CRTAM/FCER2/HLA-E/IL12B/IL12RB1/KLRK1/LAG3/LGALS9/LILRB1/PTPRC/SLAMF6,12
GO:0002456,GO:0002456,T cell mediated immunity,12/105,112/18800,1.3439444214794999e-12,4.8851851211099194e-11,2.62276552946537e-11,B2M/BTN3A2/CD70/HLA-E/IL12B/IL12RB1/IL18/IL6/LILRB1/LILRB4/PTPRC/TNFRSF1B,12
GO:0019724,GO:0019724,B cell mediated immunity,15/105,219/18800,1.3463763008162799e-12,4.8851851211099194e-11,2.62276552946537e-11,B2M/C1QA/CD27/CD28/CD70/CD74/CR2/FCER2/HLA-E/IL10/IL4R/LTA/PTPRC/SWAP70/TNF,15
GO:0001910,GO:0001910,regulation of leukocyte mediated cytotoxicity,11/105,85/18800,1.46025517059982e-12,5.2337682273083795e-11,2.8099133513852796e-11,B2M/CRTAM/HLA-E/IL12B/IL12RB1/KLRK1/LAG3/LGALS9/LILRB1/PTPRC/SLAMF6,11
GO:0050900,GO:0050900,leukocyte migration,18/105,384/18800,4.0817439087504195e-12,1.3329161497575e-10,7.156180256394009e-11,ADAM8/CCL21/CCL3/CD74/CRTAM/CSF1/CXCL13/CXCL9/GCNT1/IL10/IL6/KLRK1/LGALS9/PGF/SLAMF8/SWAP70/TNF/VCAM1,18
GO:0001909,GO:0001909,leukocyte mediated cytotoxicity,12/105,131/18800,8.84711309983021e-12,2.65323116330622e-10,1.42447073433357e-10,B2M/CRTAM/HLA-E/IL12B/IL12RB1/IL18/KLRK1/LAG3/LGALS9/LILRB1/PTPRC/SLAMF6,12
GO:0002367,GO:0002367,cytokine production involved in immune response,11/105,100/18800,9.04698808893207e-12,2.65890979933713e-10,1.42751948897991e-10,B2M/CD74/HLA-E/IL10/IL18/IL6/LILRB1/LILRB4/SEMA7A/TNF/TNFRSF1B,11
GO:0071216,GO:0071216,cellular response to biotic stimulus,15/105,256/18800,1.2724713609660698e-11,3.70276567314781e-10,1.9879463992581002e-10,CCL3/CD274/CD80/CD86/CXCL13/CXCL9/IL10/IL12B/IL18/IL6/KLRK1/LILRB1/NOS3/TNF/TNFRSF1B,15
GO:0060326,GO:0060326,cell chemotaxis,16/105,315/18800,2.1545148440841e-11,5.97369728939923e-10,3.20716757823443e-10,ADAM8/CCL21/CCL3/CD74/CSF1/CXCL13/CXCL9/EPHA2/IL10/IL6/KLRK1/LGALS9/PGF/SLAMF8/SWAP70/VCAM1,16
GO:0071887,GO:0071887,leukocyte apoptotic process,11/105,109/18800,2.3515669304791496e-11,6.38645631729848e-10,3.4287702654431e-10,ADAM8/CCL21/CD27/CD274/CD74/IL10/IL2RA/IL6/LGALS9/LILRB1/PDCD1,11
GO:0006959,GO:0006959,humoral immune response,16/105,317/18800,2.36857345554792e-11,6.38645631729848e-10,3.4287702654431e-10,BCL2/BLNK/C1QA/CD28/CD83/CR2/CXCL13/CXCL9/FCER2/HLA-E/IL6/LTA/PDCD1/PTPRC/TNF/WFDC2,16
GO:0001906,GO:0001906,cell killing,13/105,185/18800,3.3678946519538397e-11,8.91733547936246e-10,4.78755247347445e-10,B2M/CRTAM/FCER2/HLA-E/IL12B/IL12RB1/IL18/KLRK1/LAG3/LGALS9/LILRB1/PTPRC/SLAMF6,13
GO:0002709,GO:0002709,regulation of T cell mediated immunity,10/105,88/18800,5.99462892594053e-11,1.49306901807959e-09,8.01601138268051e-10,B2M/HLA-E/IL12B/IL12RB1/IL18/IL6/LILRB1/LILRB4/PTPRC/TNFRSF1B,10
GO:0002688,GO:0002688,regulation of leukocyte chemotaxis,11/105,124/18800,9.672447738528409e-11,2.31116454500285e-09,1.24082149422799e-09,CCL21/CCL3/CD74/CSF1/CXCL13/IL6/KLRK1/LGALS9/PGF/SLAMF8/SWAP70,11
GO:0042269,GO:0042269,regulation of natural killer cell mediated cytotoxicity,8/105,46/18800,1.58079390783529e-10,3.6015141822697103e-09,1.9335863466708303e-09,CRTAM/HLA-E/IL12B/KLRK1/LAG3/LGALS9/LILRB1/SLAMF6,8
GO:0042267,GO:0042267,natural killer cell mediated cytotoxicity,9/105,72/18800,2.37096728495591e-10,5.3192922522789505e-09,2.8558296184402703e-09,CRTAM/HLA-E/IL12B/IL18/KLRK1/LAG3/LGALS9/LILRB1/SLAMF6,9
GO:0050727,GO:0050727,regulation of inflammatory response,16/105,394/18800,5.85365650743326e-10,1.22884974823903e-08,6.59746699597178e-09,ADAM8/CCL3/CD28/HLA-E/IL10/IL12B/IL18/IL2RA/IL6/LTA/PTPRC/SEMA7A/SIGLEC10/SLAMF8/TNF/TNFRSF1B,16
GO:2000106,GO:2000106,regulation of leukocyte apoptotic process,9/105,85/18800,1.0802506794401702e-09,2.23581461047511e-08,1.20036750813997e-08,ADAM8/CCL21/CD27/CD274/CD74/IL10/LGALS9/LILRB1/PDCD1,9
GO:0050920,GO:0050920,regulation of chemotaxis,12/105,225/18800,4.72090994516703e-09,8.95145440570703e-08,4.80587029392555e-08,CCL21/CCL3/CD74/CSF1/CXCL13/IL6/KLRK1/LGALS9/PGF/SEMA7A/SLAMF8/SWAP70,12
GO:0002274,GO:0002274,myeloid leukocyte activation,12/105,232/18800,6.663254591341431e-09,1.2473442830543e-07,6.69676073243098e-08,C1QA/CCL3/CD74/CSF1/IL10/IL18/IL4R/IL6/LGALS9/LILRB4/PTPRC/TNF,12
GO:0002831,GO:0002831,regulation of response to biotic stimulus,14/105,351/18800,9.558087290571911e-09,1.734025836234e-07,9.30966396917953e-08,ADAM8/CD274/CLEC6A/CRTAM/HLA-E/IFNLR1/IL12B/IL12RB1/KLRK1/LAG3/LGALS9/LILRB1/SLAMF6/SLAMF8,14
GO:0032102,GO:0032102,negative regulation of response to external stimulus,15/105,429/18800,1.58613705769923e-08,2.80822699552894e-07,1.50768512967099e-07,CXCL13/HLA-E/IL10/IL12B/IL2RA/KLRK1/LGALS9/LILRB1/NOS3/PTPRC/SEMA7A/SIGLEC10/SLAMF8/TNF/TNFRSF1B,15
GO:0002507,GO:0002507,tolerance induction,6/105,31/18800,1.72710985046279e-08,3.03330289421993e-07,1.62852421641291e-07,CD274/HLA-E/IL2RA/LGALS9/LILRB4/PDCD1,6
GO:0002544,GO:0002544,chronic inflammatory response,5/105,17/18800,2.89618090588829e-08,4.91634262544793e-07,2.63949341721905e-07,CXCL13/IL10/LTA/TNF/VCAM1,5
GO:0002768,GO:0002768,immune response-regulating cell surface receptor signaling pathway,13/105,328/18800,3.61848254264812e-08,6.04245465502433e-07,3.24408213602245e-07,BCL2/BLNK/BTN3A2/CD22/CD28/CD79B/CLEC6A/CR2/FCRL3/KLRK1/LILRB1/LILRB4/PTPRC,13
GO:0042092,GO:0042092,type 2 immune response,6/105,37/18800,5.30741450112182e-08,8.71424090435589e-07,4.67851475282659e-07,CD74/CD86/IL10/IL18/IL4R/IL6,6
GO:0034612,GO:0034612,response to tumor necrosis factor,11/105,249/18800,1.46866015791696e-07,2.12630157838323e-06,1.14157198689009e-06,CCL21/CCL3/CD70/EDA2R/IL18BP/TNF/TNFRSF13C/TNFRSF17/TNFRSF1B/TNFRSF4/VCAM1,11
GO:0150076,GO:0150076,neuroinflammatory response,7/105,73/18800,1.66739879249989e-07,2.3904805127596e-06,1.28340477019632e-06,C1QA/CCL3/IL18/IL6/PTPRC/TNF/TNFRSF1B,7
GO:0002439,GO:0002439,chronic inflammatory response to antigenic stimulus,3/105,3/18800,1.69299478628519e-07,2.403725447774e-06,1.29051573081185e-06,IL10/LTA/TNF,3
GO:0002920,GO:0002920,regulation of humoral immune response,6/105,45/18800,1.79349026635942e-07,2.51003232991921e-06,1.34758992946004e-06,CR2/CXCL13/FCER2/LTA/PTPRC/TNF,6
GO:0001776,GO:0001776,leukocyte homeostasis,7/105,89/18800,6.55464085734704e-07,8.56181754655242e-06,4.59668147142139e-06,BCL2/CD74/IL2RA/IL6/LGALS9/TNFRSF13B/TNFRSF17,7
GO:0042742,GO:0042742,defense response to bacterium,12/105,364/18800,8.97683179514035e-07,1.15714511604901e-05,6.21249808906527e-06,CXCL13/EPHA2/HLA-E/IL10/IL12B/IL6/KLRK1/LTA/SLAMF8/TNF/TNFSF8/WFDC2,12
GO:0038061,GO:0038061,NIK/NF-kappaB signaling,8/105,141/18800,1.23944306770074e-06,1.54352676947986e-05,8.28690971669673e-06,CD27/CD86/IL12B/IL18/LGALS9/TNF/TNFRSF10A/TNFRSF10B,8
GO:0019058,GO:0019058,viral life cycle,11/105,317/18800,1.60416543791996e-06,1.97265364939195e-05,1.05908125586524e-05,BCL2/CD28/CD74/CD80/CD86/CR2/EPHA2/LGALS9/SCARB2/TNF/TNFRSF4,11
GO:0046718,GO:0046718,viral entry into host cell,8/105,146/18800,1.61208971098052e-06,1.9741381919049e-05,1.05987827928061e-05,CD74/CD80/CD86/CR2/EPHA2/LGALS9/SCARB2/TNFRSF4,8
GO:0097191,GO:0097191,extrinsic apoptotic signaling pathway,9/105,221/18800,4.11972380863247e-06,4.67485261527831e-05,2.50984189763872e-05,BCL2/CD27/CD70/NOS3/PTPRC/TNF/TNFRSF10A/TNFRSF10B/TNFRSF1B,9
GO:0002269,GO:0002269,leukocyte activation involved in inflammatory response,5/105,50/18800,8.56685899079832e-06,9.35985077098746e-05,5.02513074827106e-05,C1QA/CCL3/IL6/PTPRC/TNF,5
GO:0051043,GO:0051043,regulation of membrane protein ectodomain proteolysis,4/105,24/18800,8.95708158111577e-06,9.67825837018355e-05,5.19607789864262e-05,ADAM8/IL10/TNF/TNFRSF1B,4
GO:0050731,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,8/105,190/18800,1.13451259587529e-05,0.0001203730151363,6.46260452676061e-05,CD74/CD80/CLEC6A/IL12B/IL18/IL6/PTPRC/TNF,8
GO:0009615,GO:0009615,response to virus,11/105,392/18800,1.21366820758873e-05,0.0001278484179965,6.8639450789493e-05,BCL2/CXCL9/IFNLR1/IL12B/IL12RB1/IL6/LGALS9/LILRB1/NPC2/PTPRC/TNF,11
GO:0034341,GO:0034341,response to interferon-gamma,7/105,140/18800,1.35402978630907e-05,0.0001401230120409,7.52294532867787e-05,CCL21/CCL3/CD74/IL12B/IL12RB1/LGALS9/TNF,7
GO:0033674,GO:0033674,positive regulation of kinase activity,12/105,476/18800,1.39859802607405e-05,0.0001442273543379,7.74329987473684e-05,ADAM8/CCL21/CD74/CD86/CSF1/EPHA2/IL12B/IL18/PTPRC/TNF/TNFRSF10A/TNFRSF10B,12
GO:0002478,GO:0002478,antigen processing and presentation of exogenous peptide antigen,4/105,38/18800,5.85927704795992e-05,0.0005108546506072,0.0002742684125499,B2M/CD74/HLA-E/IFI30,4
GO:0002839,GO:0002839,positive regulation of immune response to tumor cell,3/105,15/18800,7.33568876518018e-05,0.0006231095167879,0.000334535973806,CD274/CRTAM/IL12B,3
GO:0014002,GO:0014002,astrocyte development,4/105,43/18800,9.58830676941895e-05,0.000784959153073,0.0004214300497686,C1QA/DLL1/IL6/TNF,4
GO:0006509,GO:0006509,membrane protein ectodomain proteolysis,4/105,44/18800,0.000105020442202,0.0008550002205871,0.0004590338033559,ADAM8/IL10/TNF/TNFRSF1B,4
GO:0032604,GO:0032604,granulocyte macrophage colony-stimulating factor production,3/105,17/18800,0.0001087442986116,0.000873222660163,0.0004688170941009,CD80/IL12B/IL18,3
GO:0060252,GO:0060252,positive regulation of glial cell proliferation,3/105,17/18800,0.0001087442986116,0.000873222660163,0.0004688170941009,IL6/LTA/TNF,3
GO:0046427,GO:0046427,positive regulation of receptor signaling pathway via JAK-STAT,4/105,45/18800,0.0001147736005326,0.0009141452898794,0.0004907876970431,IL10/IL12B/IL6/TNF,4
GO:0045165,GO:0045165,cell fate commitment,8/105,266/18800,0.0001233927655609,0.0009801387513074,0.0005262183657921,BCL2/DLL1/IL12B/IL12RB1/IL6/LY9/SLAMF6/SLAMF8,8
GO:0045765,GO:0045765,regulation of angiogenesis,9/105,345/18800,0.0001360825227843,0.0010676479984472,0.0005732004619087,CXCL13/DLL1/EPHA2/IL10/IL6/LRG1/NOS3/PGF/TNF,9
GO:0035094,GO:0035094,response to nicotine,4/105,49/18800,0.0001604400554085,0.0012343804262979,0.0006627160183451,B2M/BCL2/TNF/VCAM1,4
GO:1903978,GO:1903978,regulation of microglial cell activation,3/105,20/18800,0.0001800974957756,0.0013571962566271,0.0007286535659046,CCL3/IL6/PTPRC,3
GO:0045190,GO:0045190,isotype switching,4/105,52/18800,0.0002023870837339,0.001505862377453,0.0008084696562748,CD28/IL10/PTPRC/SWAP70,4
GO:0002532,GO:0002532,production of molecular mediator involved in inflammatory response,5/105,97/18800,0.0002117231384397,0.0015673911936383,0.0008415033395762,IL4R/IL6/LILRB4/SLAMF8/TNF,5
GO:0045661,GO:0045661,regulation of myoblast differentiation,4/105,54/18800,0.0002344066675862,0.0017180079701643,0.0009223667009101,CXCL9/DLL1/IL18/TNF,4
GO:0051048,GO:0051048,negative regulation of secretion,6/105,167/18800,0.0003498162348601,0.0024654914010887,0.0013236767286517,CD74/IL12B/LGALS9/LILRB1/TNF/TNFRSF1B,6
GO:1901214,GO:1901214,regulation of neuron death,8/105,313/18800,0.0003716913168632,0.0025886274413771,0.0013897861910153,ADAM8/BCL2/C1QA/CCL3/CSF1/IL10/TNF/TNFRSF1B,8
GO:0034113,GO:0034113,heterotypic cell-cell adhesion,4/105,61/18800,0.000375395629881,0.0026082452865728,0.0014003186492264,IL10/PTPRC/TNF/VCAM1,4
GO:0040013,GO:0040013,negative regulation of locomotion,9/105,396/18800,0.00037738055531,0.0026158524812646,0.0014044028113449,BCL2/CCL21/CD74/CXCL13/KLRK1/SEMA7A/SLAMF8/STC1/TNF,9
GO:0048660,GO:0048660,regulation of smooth muscle cell proliferation,6/105,170/18800,0.0003846771181971,0.0026476956683403,0.0014214988294773,IL10/IL12B/IL18/IL6/NOS3/TNF,6
GO:0048659,GO:0048659,smooth muscle cell proliferation,6/105,173/18800,0.0004221994110084,0.0028265240750655,0.0015175084932301,IL10/IL12B/IL18/IL6/NOS3/TNF,6
GO:0002526,GO:0002526,acute inflammatory response,5/105,113/18800,0.000429759257495,0.0028640872058453,0.0015376754433345,ADAM8/HLA-E/IL6/TNF/VCAM1,5
GO:0048771,GO:0048771,tissue remodeling,6/105,174/18800,0.0004353222707976,0.0028945976331996,0.0015540559274247,ADAM8/EPHA2/IL12B/IL18/IL6/NOS3,6
GO:0002418,GO:0002418,immune response to tumor cell,3/105,27/18800,0.0004491473663771,0.0029632574145549,0.0015909180940233,CD274/CRTAM/IL12B,3
GO:0031100,GO:0031100,animal organ regeneration,4/105,65/18800,0.0004787755162728,0.0030993859963122,0.0016640030115764,IL10/IL6/PGF/TNF,4
GO:0060284,GO:0060284,regulation of cell development,10/105,500/18800,0.0004880623899665,0.0031456477283151,0.001688840079778,B2M/BCL2/DLL1/IL6/LILRB1/LTA/SEMA7A/SLAMF8/TNF/TNFRSF1B,10
GO:0048873,GO:0048873,homeostasis of number of cells within a tissue,3/105,28/18800,0.0005010092263726,0.0032079871815014,0.0017223089790908,BCL2/CSF1/NOS3,3
GO:0051924,GO:0051924,regulation of calcium ion transport,7/105,251/18800,0.0005210410171615,0.0033217777645071,0.0017834010383038,BCL2/CCL3/CXCL9/FCRL3/LILRB1/NOS3/STC1,7
GO:0006816,GO:0006816,calcium ion transport,9/105,424/18800,0.0006174293390616,0.003804244921388,0.0020424287305602,BCL2/CCL21/CCL3/CXCL9/FCRL3/LILRB1/NOS3/PTPRC/STC1,9
GO:0022612,GO:0022612,gland morphogenesis,5/105,123/18800,0.0006330847238475,0.0038291299134879,0.0020557890225169,BCL2/CSF1/EPHA2/IL6/TNF,5
GO:0002606,GO:0002606,positive regulation of dendritic cell antigen processing and presentation,2/105,7/18800,0.000637102595337,0.0038291299134879,0.0020557890225169,CCL21/CD74,2
GO:0046836,GO:0046836,glycolipid transport,2/105,7/18800,0.000637102595337,0.0038291299134879,0.0020557890225169,NPC2/PSAP,2
GO:0071316,GO:0071316,cellular response to nicotine,2/105,7/18800,0.000637102595337,0.0038291299134879,0.0020557890225169,B2M/TNF,2
GO:0051091,GO:0051091,positive regulation of DNA-binding transcription factor activity,7/105,265/18800,0.000718239205372,0.0042686768139542,0.0022917736230072,ADAM8/EDA2R/IL10/IL18/IL6/LGALS9/TNF,7
GO:0001935,GO:0001935,endothelial cell proliferation,6/105,194/18800,0.0007715390049726,0.0045441946605503,0.0024396940585465,EPHA2/IL10/IL12B/LRG1/PGF/TNF,6
GO:0035924,GO:0035924,cellular response to vascular endothelial growth factor stimulus,4/105,74/18800,0.000783013255033,0.004593365182719,0.0024660928023838,DLL1/IL12B/PGF/VCAM1,4
GO:0070997,GO:0070997,neuron death,8/105,353/18800,0.0008186708670584,0.0047739557108822,0.0025630485165425,ADAM8/BCL2/C1QA/CCL3/CSF1/IL10/TNF/TNFRSF1B,8
GO:0006809,GO:0006809,nitric oxide biosynthetic process,4/105,75/18800,0.0008236065636232,0.0047932271098788,0.0025733949741976,IL10/KLRK1/NOS3/TNF,4
GO:0031644,GO:0031644,regulation of nervous system process,5/105,138/18800,0.0010632648895121,0.0060010374708053,0.0032218460159156,CCL3/IL10/NOS3/TNF/TNFRSF1B,5
GO:0051384,GO:0051384,response to glucocorticoid,5/105,139/18800,0.0010981081116774,0.0060255335178677,0.003234997490476,BCL2/IL10/IL6/STC1/TNF,5
GO:1903900,GO:1903900,regulation of viral life cycle,5/105,139/18800,0.0010981081116774,0.0060255335178677,0.003234997490476,BCL2/CD28/CD74/LGALS9/TNF,5
GO:0045445,GO:0045445,myoblast differentiation,4/105,81/18800,0.0010989064190463,0.0060255335178677,0.003234997490476,CXCL9/DLL1/IL18/TNF,4
GO:0046209,GO:0046209,nitric oxide metabolic process,4/105,81/18800,0.0010989064190463,0.0060255335178677,0.003234997490476,IL10/KLRK1/NOS3/TNF,4
GO:0001666,GO:0001666,response to hypoxia,7/105,286/18800,0.0011203957265454,0.0061319237249853,0.0032921164247606,ADAM8/BCL2/LTA/PGF/STC1/TNF/VCAM1,7
GO:0051346,GO:0051346,negative regulation of hydrolase activity,8/105,371/18800,0.0011269552759788,0.0061563597697057,0.0033052356851735,CD27/GZMA/KLRK1/NOS3/PLAUR/SERPINA9/TNF/WFDC2,8
GO:2001057,GO:2001057,reactive nitrogen species metabolic process,4/105,82/18800,0.0011503492411276,0.0062724979956847,0.0033675881504741,IL10/KLRK1/NOS3/TNF,4
GO:0045191,GO:0045191,regulation of isotype switching,3/105,38/18800,0.0012389394358317,0.0066811798200172,0.0035870018625045,CD28/IL10/PTPRC,3
GO:0033627,GO:0033627,cell adhesion mediated by integrin,4/105,86/18800,0.0013730626907101,0.0072449394039442,0.0038896739551628,CCL21/CXCL13/EPHA2/SWAP70,4
GO:0034103,GO:0034103,regulation of tissue remodeling,4/105,86/18800,0.0013730626907101,0.0072449394039442,0.0038896739551628,ADAM8/IL12B/IL18/IL6,4
GO:0075294,GO:0075294,positive regulation by symbiont of entry into host,2/105,11/18800,0.001644420327226,0.0084788620030131,0.0045521441745372,CD74/LGALS9,2
GO:0002347,GO:0002347,response to tumor cell,3/105,42/18800,0.0016589449340393,0.0085387726114564,0.0045843090720342,CD274/CRTAM/IL12B,3
GO:0035304,GO:0035304,regulation of protein dephosphorylation,4/105,91/18800,0.0016917295863964,0.0086771260984625,0.004658588500061,FCRL3/PTPRC/SWAP70/TNF,4
GO:0071496,GO:0071496,cellular response to external stimulus,7/105,309/18800,0.0017447613884581,0.0089180064707453,0.0047879127163364,BCL2/DCTPP1/PTPRC/TNFRSF10A/TNFRSF10B/TNFRSF8/VCAM1,7
GO:0010455,GO:0010455,positive regulation of cell fate commitment,2/105,12/18800,0.0019661234219672,0.0098440148844322,0.0052850695051177,IL12B/IL12RB1,2
GO:1990868,GO:1990868,response to chemokine,4/105,97/18800,0.0021379069855804,0.0105779606576109,0.0056791114148237,CCL21/CCL3/CXCL13/CXCL9,4
GO:0019233,GO:0019233,sensory perception of pain,4/105,99/18800,0.0023030725013412,0.0111724169730847,0.0059982640148471,CCL3/IL10/IL12B/TNF,4
GO:0001768,GO:0001768,establishment of T cell polarity,2/105,13/18800,0.0023151482729497,0.0111724169730847,0.0059982640148471,CCL21/CRTAM,2
GO:1900121,GO:1900121,negative regulation of receptor binding,2/105,13/18800,0.0023151482729497,0.0111724169730847,0.0059982640148471,B2M/IL10,2
GO:0007204,GO:0007204,positive regulation of cytosolic calcium ion concentration,7/105,325/18800,0.0023188752479012,0.0111724169730847,0.0059982640148471,BCL2/CCL21/CCL3/CXCL13/CXCL9/PTPRC/SWAP70,7
GO:0001503,GO:0001503,ossification,8/105,420/18800,0.0024532123378019,0.011781031145098,0.0063250177061663,BCL2/CCL3/CSF1/EPHA2/IL6/SEMA7A/STC1/TNF,8
GO:0051235,GO:0051235,maintenance of location,7/105,331/18800,0.0025682356480012,0.0123132864102378,0.0066107757128083,CCL21/CCL3/CXCL9/IL10/IL6/PTPRC/TNF,7
GO:0006898,GO:0006898,receptor-mediated endocytosis,6/105,246/18800,0.002585104518663,0.0123686985259387,0.0066405254527613,B2M/CCL21/DLL1/LILRB1/LILRB4/SCARB2,6
GO:0090715,GO:0090715,immunological memory formation process,2/105,14/18800,0.0026911855332221,0.012716067977717,0.0068270216860721,IL12B/IL12RB1,2
GO:0060402,GO:0060402,calcium ion transport into cytosol,5/105,171/18800,0.0027265705168455,0.0128625854719246,0.0069056842185544,BCL2/CCL21/CCL3/CXCL9/PTPRC,5
GO:0038084,GO:0038084,vascular endothelial growth factor signaling pathway,3/105,50/18800,0.002742331225592,0.0129162042820753,0.0069344711659285,DLL1/IL12B/PGF,3
GO:0051341,GO:0051341,regulation of oxidoreductase activity,4/105,106/18800,0.0029502564810377,0.013851124277588,0.007436412418153,FCER2/GZMA/SLAMF8/TNF,4
GO:1902166,GO:1902166,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,2/105,15/18800,0.0030939284017714,0.0143650167026956,0.0077123117556421,BCL2/CD74,2
GO:0001936,GO:0001936,regulation of endothelial cell proliferation,5/105,178/18800,0.0032393559037771,0.0150165094656167,0.0080620861692875,IL10/IL12B/LRG1/PGF/TNF,5
GO:0051960,GO:0051960,regulation of nervous system development,8/105,440/18800,0.0032593605392687,0.015085449803009,0.0080990989612329,B2M/CLSTN3/DLL1/IL6/LTA/SEMA7A/TNF/TNFRSF1B,8
GO:0010224,GO:0010224,response to UV-B,2/105,16/18800,0.0035230726051768,0.0161533703379323,0.0086724457429346,BCL2/IL12B,2
GO:1901741,GO:1901741,positive regulation of myoblast fusion,2/105,16/18800,0.0035230726051768,0.0161533703379323,0.0086724457429346,CXCL9/IL4R,2
GO:0061138,GO:0061138,morphogenesis of a branching epithelium,5/105,185/18800,0.0038183209733816,0.017371587214812,0.0093264838505768,BCL2/CSF1/EPHA2/IL10/TNF,5
GO:0002040,GO:0002040,sprouting angiogenesis,5/105,186/18800,0.0039066992971548,0.0176915088356521,0.009498243851164,DLL1/EPHA2/IL10/IL12B/PGF,5
GO:2001267,GO:2001267,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,2/105,17/18800,0.0039783163793854,0.0178235851204481,0.0095691531654345,LGALS9/PLAUR,2
GO:0031099,GO:0031099,regeneration,5/105,188/18800,0.0040878406644049,0.018230900929721,0.0097878334892469,BCL2/IL10/IL6/PGF/TNF,5
GO:0061614,GO:0061614,miRNA transcription,3/105,60/18800,0.00459885823055,0.0201131612196231,0.0107983842224226,IL10/LILRB4/TNF,3
GO:0055074,GO:0055074,calcium ion homeostasis,8/105,468/18800,0.004718631183297,0.0206063254795097,0.0110631549914167,BCL2/CCL21/CCL3/CXCL13/CXCL9/PTPRC/STC1/SWAP70,8
GO:0045428,GO:0045428,regulation of nitric oxide biosynthetic process,3/105,61/18800,0.0048173131926536,0.0209439104633271,0.0112443981248643,IL10/KLRK1/TNF,3
GO:0019730,GO:0019730,antimicrobial humoral response,4/105,122/18800,0.0048743284200366,0.0211292790951146,0.0113439191144774,CXCL13/CXCL9/HLA-E/WFDC2,4
GO:0010744,GO:0010744,positive regulation of macrophage derived foam cell differentiation,2/105,19/18800,0.0049659080223502,0.0213374322773209,0.011455672707761,CSF1/IL18,2
GO:0048643,GO:0048643,positive regulation of skeletal muscle tissue development,2/105,19/18800,0.0049659080223502,0.0213374322773209,0.011455672707761,BCL2/DLL1,2
GO:0001763,GO:0001763,morphogenesis of a branching structure,5/105,199/18800,0.0051930303333535,0.0221221397029305,0.0118769676097107,BCL2/CSF1/EPHA2/IL10/TNF,5
GO:0034599,GO:0034599,cellular response to oxidative stress,6/105,284/18800,0.0052105709965784,0.0221221397029305,0.0118769676097107,BCL2/IL10/IL18BP/IL6/NOS3/TNF,6
GO:0080164,GO:0080164,regulation of nitric oxide metabolic process,3/105,64/18800,0.0055099250454541,0.0221221397029305,0.0118769676097107,IL10/KLRK1/TNF,3
GO:0001815,GO:0001815,positive regulation of antibody-dependent cellular cytotoxicity,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,HLA-E,1
GO:0002413,GO:0002413,tolerance induction to tumor cell,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,CD274,1
GO:0002845,GO:0002845,positive regulation of tolerance induction to tumor cell,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,CD274,1
GO:0003421,GO:0003421,growth plate cartilage axis specification,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,STC1,1
GO:0006253,GO:0006253,dCTP catabolic process,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,DCTPP1,1
GO:0014740,GO:0014740,negative regulation of muscle hyperplasia,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,NOS3,1
GO:0021688,GO:0021688,cerebellar molecular layer formation,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,DLL1,1
GO:0032078,GO:0032078,negative regulation of endodeoxyribonuclease activity,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,GZMA,1
GO:0032848,GO:0032848,negative regulation of cellular pH reduction,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,BCL2,1
GO:0044722,GO:0044722,renal phosphate excretion,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,STC1,1
GO:0045994,GO:0045994,positive regulation of translational initiation by iron,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,TNF,1
GO:0046065,GO:0046065,dCTP metabolic process,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,DCTPP1,1
GO:0046671,GO:0046671,negative regulation of retinal cell programmed cell death,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,BCL2,1
GO:0060034,GO:0060034,notochord cell differentiation,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,EPHA2,1
GO:0060035,GO:0060035,notochord cell development,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,EPHA2,1
GO:0060611,GO:0060611,mammary gland fat development,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,CSF1,1
GO:0060853,GO:0060853,Notch signaling pathway involved in arterial endothelial cell fate commitment,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,DLL1,1
GO:0060945,GO:0060945,cardiac neuron differentiation,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,VCAM1,1
GO:0061048,GO:0061048,negative regulation of branching involved in lung morphogenesis,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,TNF,1
GO:0071283,GO:0071283,cellular response to iron(III) ion,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,B2M,1
GO:0140460,GO:0140460,response to Gram-negative bacterium,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,TNF,1
GO:1901554,GO:1901554,response to paracetamol,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,TNF,1
GO:1902483,GO:1902483,cytotoxic T cell pyroptotic process,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,GZMA,1
GO:1903402,GO:1903402,regulation of renal phosphate excretion,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,STC1,1
GO:1903403,GO:1903403,negative regulation of renal phosphate excretion,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,STC1,1
GO:1903771,GO:1903771,positive regulation of beta-galactosidase activity,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,PSAP,1
GO:2000548,GO:2000548,negative regulation of dendritic cell dendrite assembly,1/105,1/18800,0.0055851063829787,0.0221221397029305,0.0118769676097107,CCL21,1
GO:0000302,GO:0000302,response to reactive oxygen species,5/105,203/18800,0.0056428456064214,0.022290757039345,0.0119674951386896,BCL2/IL10/IL18BP/IL6/NOS3,5
GO:0014823,GO:0014823,response to activity,3/105,65/18800,0.005753367764608,0.0226664180431409,0.0121691805829653,IL10/IL6/TNF,3
GO:0003177,GO:0003177,pulmonary valve development,2/105,21/18800,0.0060543387207382,0.0235678165566221,0.0126531247715394,NOS3/TNFRSF1B,2
GO:0035303,GO:0035303,regulation of dephosphorylation,4/105,130/18800,0.0060938333774388,0.0236901802861016,0.0127188195945152,FCRL3/PTPRC/SWAP70/TNF,4
GO:0043523,GO:0043523,regulation of neuron apoptotic process,5/105,207/18800,0.0061195384980265,0.0237586838120211,0.0127555978704606,ADAM8/BCL2/CCL3/IL10/TNF,5
GO:0030100,GO:0030100,regulation of endocytosis,5/105,208/18800,0.0062430075995887,0.0242060677245266,0.0129957900177523,B2M/CCL21/CD22/DLL1/LILRB1,5
GO:0007398,GO:0007398,ectoderm development,2/105,22/18800,0.0066356404556502,0.0252618488331036,0.0135626193659935,EDA2R/ZBTB17,2
GO:0010888,GO:0010888,negative regulation of lipid storage,2/105,22/18800,0.0066356404556502,0.0252618488331036,0.0135626193659935,IL6/TNF,2
GO:0051000,GO:0051000,positive regulation of nitric-oxide synthase activity,2/105,22/18800,0.0066356404556502,0.0252618488331036,0.0135626193659935,FCER2/TNF,2
GO:1903798,GO:1903798,regulation of production of miRNAs involved in gene silencing by miRNA,2/105,22/18800,0.0066356404556502,0.0252618488331036,0.0135626193659935,IL6/TNF,2
GO:2000810,GO:2000810,regulation of bicellular tight junction assembly,2/105,22/18800,0.0066356404556502,0.0252618488331036,0.0135626193659935,EPHA2/TNF,2
GO:0071260,GO:0071260,cellular response to mechanical stimulus,3/105,70/18800,0.0070668327406478,0.0267992534513084,0.0143880234678861,TNFRSF10A/TNFRSF10B/TNFRSF8,3
GO:0030728,GO:0030728,ovulation,2/105,23/18800,0.0072412828684752,0.027076501718128,0.0145368729340355,IL4R/NOS3,2
GO:1900120,GO:1900120,regulation of receptor binding,2/105,23/18800,0.0072412828684752,0.027076501718128,0.0145368729340355,B2M/IL10,2
GO:1990840,GO:1990840,response to lectin,2/105,23/18800,0.0072412828684752,0.027076501718128,0.0145368729340355,CLEC6A/KLRK1,2
GO:1990858,GO:1990858,cellular response to lectin,2/105,23/18800,0.0072412828684752,0.027076501718128,0.0145368729340355,CLEC6A/KLRK1,2
GO:1901863,GO:1901863,positive regulation of muscle tissue development,2/105,24/18800,0.0078709812605921,0.0291712659834557,0.0156615131208969,BCL2/DLL1,2
GO:0070555,GO:0070555,response to interleukin-1,4/105,141/18800,0.008079929031325,0.0297953719235437,0.0159965840559417,CCL21/CCL3/IL6/LGALS9,4
GO:0006929,GO:0006929,substrate-dependent cell migration,2/105,25/18800,0.0085244533012731,0.0311946360613103,0.0167478230890937,ADAM8/PTPRC,2
GO:0002534,GO:0002534,cytokine production involved in inflammatory response,3/105,75/18800,0.0085442946680349,0.0311946360613103,0.0167478230890937,IL6/LILRB4/TNF,3
GO:0043299,GO:0043299,leukocyte degranulation,3/105,76/18800,0.0088598548660746,0.0323065923714558,0.0173448118639753,CCL3/IL4R/LGALS9,3
GO:0060249,GO:0060249,anatomical structure homeostasis,6/105,319/18800,0.0090112035927372,0.0327771378206125,0.0175974390118723,ADAM8/B2M/BCL2/CSF1/IL6/NOS3,6
GO:0043154,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,3/105,77/18800,0.009182178226612,0.0333041508275116,0.0178803825470317,CD27/PLAUR/TNF,3
GO:0060384,GO:0060384,innervation,2/105,26/18800,0.0092014190105272,0.0333041508275116,0.0178803825470317,LRIG1/VCAM1,2
GO:0010594,GO:0010594,regulation of endothelial cell migration,5/105,230/18800,0.0094226010911721,0.0339791712968772,0.0182427885510714,CXCL13/EPHA2/NOS3/STC1/TNF,5
GO:0048145,GO:0048145,regulation of fibroblast proliferation,3/105,79/18800,0.0098472306296473,0.0354024386629099,0.0190069144734879,CD74/IFI30/LTA,3
GO:0097305,GO:0097305,response to alcohol,5/105,235/18800,0.0102764983754587,0.0366982123031263,0.0197025913727857,CCL21/CCL3/CD27/TNF/VCAM1,5
GO:0048144,GO:0048144,fibroblast proliferation,3/105,81/18800,0.0105396729537514,0.0368261486677741,0.0197712780405055,CD74/IFI30/LTA,3
GO:0001879,GO:0001879,detection of yeast,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,CLEC6A,1
GO:0002037,GO:0002037,negative regulation of L-glutamate import across plasma membrane,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,TNF,1
GO:0002384,GO:0002384,hepatic immune response,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,IL6,1
GO:0014806,GO:0014806,smooth muscle hyperplasia,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,NOS3,1
GO:0021693,GO:0021693,cerebellar Purkinje cell layer structural organization,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,DLL1,1
GO:0035759,GO:0035759,mesangial cell-matrix adhesion,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,CCL21,1
GO:0042488,GO:0042488,positive regulation of odontogenesis of dentin-containing tooth,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,CSF1,1
GO:0044855,GO:0044855,plasma membrane raft distribution,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,PTPRC,1
GO:0044856,GO:0044856,plasma membrane raft localization,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,PTPRC,1
GO:0060302,GO:0060302,negative regulation of cytokine activity,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,IL10,1
GO:0060557,GO:0060557,positive regulation of vitamin D biosynthetic process,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,TNF,1
GO:0072564,GO:0072564,blood microparticle formation,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,TNF,1
GO:0097102,GO:0097102,endothelial tip cell fate specification,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,DLL1,1
GO:0120190,GO:0120190,negative regulation of bile acid secretion,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,TNF,1
GO:0140039,GO:0140039,cell-cell adhesion in response to extracellular stimulus,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,VCAM1,1
GO:1904432,GO:1904432,regulation of ferrous iron binding,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,B2M,1
GO:1904434,GO:1904434,positive regulation of ferrous iron binding,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,B2M,1
GO:1904437,GO:1904437,positive regulation of transferrin receptor binding,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,B2M,1
GO:1990267,GO:1990267,response to transition metal nanoparticle,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,TNF,1
GO:1990268,GO:1990268,response to gold nanoparticle,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,TNF,1
GO:2000471,GO:2000471,regulation of hematopoietic stem cell migration,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,PTPRC,1
GO:2000473,GO:2000473,positive regulation of hematopoietic stem cell migration,1/105,2/18800,0.0111393147892654,0.0368261486677741,0.0197712780405055,PTPRC,1
GO:0001649,GO:0001649,osteoblast differentiation,5/105,241/18800,0.0113695997966354,0.0373802443545169,0.0200687617655203,CCL3/EPHA2/IL6/SEMA7A/TNF,5
GO:0051402,GO:0051402,neuron apoptotic process,5/105,241/18800,0.0113695997966354,0.0373802443545169,0.0200687617655203,ADAM8/BCL2/CCL3/IL10/TNF,5
GO:1903203,GO:1903203,regulation of oxidative stress-induced neuron death,2/105,29/18800,0.0113705132538068,0.0373802443545169,0.0200687617655203,IL10/TNF,2
GO:0040018,GO:0040018,positive regulation of multicellular organism growth,2/105,30/18800,0.0121387002581344,0.0395151329282622,0.0212149439513852,BCL2/CSF1,2
GO:0070168,GO:0070168,negative regulation of biomineral tissue development,2/105,30/18800,0.0121387002581344,0.0395151329282622,0.0212149439513852,CCL3/NOS3,2
GO:0010039,GO:0010039,response to iron ion,2/105,31/18800,0.0129290156996745,0.0418023950949873,0.022442932700842,B2M/BCL2,2
GO:0061099,GO:0061099,negative regulation of protein tyrosine kinase activity,2/105,31/18800,0.0129290156996745,0.0418023950949873,0.022442932700842,LILRB4/PTPRC,2
GO:0110150,GO:0110150,negative regulation of biomineralization,2/105,31/18800,0.0129290156996745,0.0418023950949873,0.022442932700842,CCL3/NOS3,2
GO:0014031,GO:0014031,mesenchymal cell development,3/105,88/18800,0.0131816969481299,0.0424791747045547,0.022806283154717,BCL2/SEMA7A/TCOF1,3
GO:0048864,GO:0048864,stem cell development,3/105,88/18800,0.0131816969481299,0.0424791747045547,0.022806283154717,PTPRC/SEMA7A/TCOF1,3
GO:0007568,GO:0007568,aging,4/105,163/18800,0.0132304012309956,0.0425894295924381,0.0228654769646191,C1QA/IL10/TNFRSF1B/VCAM1,4
GO:0033028,GO:0033028,myeloid cell apoptotic process,2/105,32/18800,0.013741193348964,0.0438494758443053,0.0235419724899675,BCL2/IL6,2
GO:0043304,GO:0043304,regulation of mast cell degranulation,2/105,32/18800,0.013741193348964,0.0438494758443053,0.0235419724899675,IL4R/LGALS9,2
GO:1903034,GO:1903034,regulation of response to wounding,4/105,166/18800,0.0140628164126105,0.0446817485801755,0.0239888043271729,IL10/NOS3/SIGLEC10/TNF,4
GO:1901099,GO:1901099,negative regulation of signal transduction in absence of ligand,2/105,33/18800,0.0145749692103609,0.0459119340935163,0.0246492681743453,BCL2/TNF,2
GO:0022404,GO:0022404,molting cycle process,3/105,92/18800,0.0148459312796343,0.0466155897765441,0.0250270478949301,BCL2/LRIG1/TNF,3
GO:0022405,GO:0022405,hair cycle process,3/105,92/18800,0.0148459312796343,0.0466155897765441,0.0250270478949301,BCL2/LRIG1/TNF,3
GO:0098773,GO:0098773,skin epidermis development,3/105,93/18800,0.0152797136480846,0.0477734876720432,0.0256487018571991,BCL2/DLL1/TNF,3
GO:0033006,GO:0033006,regulation of mast cell activation involved in immune response,2/105,34/18800,0.0154300815057876,0.0480392050270229,0.0257913605900709,IL4R/LGALS9,2
GO:1901797,GO:1901797,negative regulation of signal transduction by p53 class mediator,2/105,34/18800,0.0154300815057876,0.0480392050270229,0.0257913605900709,BCL2/CD74,2
GO:0002355,GO:0002355,detection of tumor cell,1/105,3/18800,0.0166627945183395,0.0486798738463219,0.0261353238285978,CRTAM,1
GO:0006808,GO:0006808,regulation of nitrogen utilization,1/105,3/18800,0.0166627945183395,0.0486798738463219,0.0261353238285978,BCL2,1
GO:0010693,GO:0010693,negative regulation of alkaline phosphatase activity,1/105,3/18800,0.0166627945183395,0.0486798738463219,0.0261353238285978,TNF,1
GO:0014028,GO:0014028,notochord formation,1/105,3/18800,0.0166627945183395,0.0486798738463219,0.0261353238285978,EPHA2,1
GO:0014042,GO:0014042,positive regulation of neuron maturation,1/105,3/18800,0.0166627945183395,0.0486798738463219,0.0261353238285978,BCL2,1
GO:0021747,GO:0021747,cochlear nucleus development,1/105,3/18800,0.0166627945183395,0.0486798738463219,0.0261353238285978,BCL2,1
GO:0048320,GO:0048320,axial mesoderm formation,1/105,3/18800,0.0166627945183395,0.0486798738463219,0.0261353238285978,EPHA2,1
GO:0097026,GO:0097026,dendritic cell dendrite assembly,1/105,3/18800,0.0166627945183395,0.0486798738463219,0.0261353238285978,CCL21,1
GO:0150064,GO:0150064,vertebrate eye-specific patterning,1/105,3/18800,0.0166627945183395,0.0486798738463219,0.0261353238285978,C1QA,1
GO:1901491,GO:1901491,negative regulation of lymphangiogenesis,1/105,3/18800,0.0166627945183395,0.0486798738463219,0.0261353238285978,EPHA2,1
GO:1901647,GO:1901647,positive regulation of synoviocyte proliferation,1/105,3/18800,0.0166627945183395,0.0486798738463219,0.0261353238285978,TNF,1
GO:1905451,GO:1905451,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,1/105,3/18800,0.0166627945183395,0.0486798738463219,0.0261353238285978,PTPRC,1
GO:2000676,GO:2000676,positive regulation of type B pancreatic cell apoptotic process,1/105,3/18800,0.0166627945183395,0.0486798738463219,0.0261353238285978,IL6,1
GO:2000978,GO:2000978,negative regulation of forebrain neuron differentiation,1/105,3/18800,0.0166627945183395,0.0486798738463219,0.0261353238285978,B2M,1
GO:2001272,GO:2001272,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,1/105,3/18800,0.0166627945183395,0.0486798738463219,0.0261353238285978,TNF,1
GO:0035265,GO:0035265,organ growth,4/105,175/18800,0.0167571753991734,0.048858470732312,0.0262312091931505,BCL2/DLL1/PSAP/STC1,4
